Fund Holdings — Birchview Capital, LP

Total Portfolio Value:
$173.11M
Total Bought:
$28.92M
Total Sold:
$60.95M
Net Transaction:
-$32.03M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
KLA Corporation(KLAC)178,471166,938-11,533$53.85M$32.54M18.80%-$21.31M
Bristol-Myers Squibb Company(BMY)297,243224,245-72,998$17.13M$13.99M8.08%-$3.13M
Lam Research Corporation(LRCX)35,00030,000-5,000$15.17M$9.86M5.69%-$5.31M
Biodesix, Inc.(BDSX)286,804286,8040$6.47M$8.56M4.94%+$2.09M
Corcept Therapeutics Incorporated(CORT)57,20055,200-2,000$4.97M$6.36M3.67%+$1.39M
Ovintiv Inc.(OVV)107,500107,5000$5.66M$6.22M3.59%+$555.8K
Ultragenyx Pharmaceutical Inc.(RARE)0373,671+373,671$0$5.62M3.24%+$5.62M
Solid Biosciences Inc666,196715,955+49,759$6.66M$5.18M2.99%-$1.48M
Protagonist Therapeutics Inc35,01835,000-18$4.29M$4.93M2.85%+$638.6K
Prothena Corp PlcSHS
SHS
449,019449,0190$4.40M$3.76M2.17%-$633.1K
Halozyme Therapeutics, Inc.(HALO)33,25133,351+100$2.60M$3.68M2.13%+$1.08M
Stoke Therapeutics, Inc.(STOK)178,110138,000-40,110$5.83M$3.59M2.07%-$2.24M
Neurocrine Biosciences, Inc.(NBIX)27,19025,190-2,000$4.58M$3.57M2.06%-$1.01M
Acadia Pharmaceuticals Inc171,000171,0000$4.33M$3.45M1.99%-$880.6K
Intellia Therapeutics, Inc.(NTLA)500281,365+280,865$260.0K$3.39M1.96%+$3.13M
Nektar Therapeutics(NKTR)81,00046,000-35,000$5.65M$2.79M1.61%-$2.87M
Vir Biotechnology, Inc.(VIR)220,000226,992+6,992$2.24M$2.54M1.47%+$296.0K
Zenas BioPharma, Inc.(ZBIO)93,60193,380-221$2.38M$2.52M1.45%+$142.9K
Contineum Therapeutics Inc (Ctnm) P @ 15.0 01/15/2027PUT03,500+3,500$0$2.27M1.31%+$2.27M
ABIVAX Société AnonymeADS(ABVX)17,00021,000+4,000$2.27M$2.08M1.20%-$186.0K
Biogen Inc.(BIIB)9,0009,0000$1.94M$2.03M1.17%+$88.4K
Alkermes plcSHS(ALKS)50,00050,0000$2.62M$2.03M1.17%-$593.8K
Definium Therapeutics, Inc.(DFTX)20,00052,000+32,000$940.8K$1.98M1.14%+$1.04M
Cytokinetics, Incorporated(CYTK)30,00030,0000$2.56M$1.98M1.14%-$578.4K
Celldex Therapeutics, Inc.(CLDX)69,90057,200-12,700$2.60M$1.85M1.07%-$747.1K
EQT Corporation(EQT)34,61934,6190$1.84M$1.68M0.97%-$159.6K
Compass Therapeutics, Inc.(CMPX)1,675,0001,575,000-100,000$3.67M$1.64M0.95%-$2.03M
Xenon Pharmaceuticals Inc.(XENE)21,03242,995+21,963$1.27M$1.60M0.92%+$329.5K
Relmada Therapeutics, Inc.(RLMD)408,100408,1000$2.82M$1.54M0.89%-$1.29M
Travere Therapeutics, Inc.(TVTX)29,00025,000-4,000$1.65M$1.47M0.85%-$175.5K
Adagene IncADS240,000430,000+190,000$1.01M$1.38M0.79%+$368.0K
United Therapeutics Corporation(UTHR)4,5062,500-2,006$2.44M$1.35M0.78%-$1.09M
Freeport-McMoRan Inc.CL B(FCX)18,03518,027-8$1.13M$1.26M0.73%+$127.7K
Quince Therapeutics Inc040,601+40,601$0$1.26M0.73%+$1.26M
Valneva SEADS(VALN)0201,390+201,390$0$1.25M0.72%+$1.25M
BridgeBio Pharma, Inc.(BBIO)8,74118,741+10,000$651.0K$1.23M0.71%+$582.1K
Immunome, Inc.(IMNM)50,00055,600+5,600$1.06M$1.20M0.69%+$136.5K
Axsome Therapeutics, Inc.(AXSM)6,0006,0000$1.47M$1.11M0.64%-$362.3K
Annexon, Inc.PUT(ANNX)04,370+4,370$0$1.05M0.61%+$1.05M
Jatt Ii Acquisition Corp090,455+90,455$0$1.02M0.59%+$1.02M
Foghorn Therapeutics Inc.(FHTX)281,937282,307+370$1.38M$1.01M0.58%-$368.0K
Pharvaris N V
COM
29,84729,8470$1.03M$946.7K0.55%-$85.4K
Quidelortho Corp89,37789,3770$1.57M$942.0K0.54%-$623.4K
Blossomhill Therapeutics Inc050,000+50,000$0$932.0K0.54%+$932.0K
Disc Medicine, Inc.PUT(IRON)0450+450$0$841.5K0.49%+$841.5K
Castle Biosciences, Inc.(CSTL)12,98422,935+9,951$309.7K$814.9K0.47%+$505.2K
Bright Minds Biosciences Inc.(DRUG)015,400+15,400$0$767.2K0.44%+$767.2K
Harrow, Inc.(HROW)24,00024,0000$1.02M$739.2K0.43%-$280.1K
Bicycle Therapeutics PlcADS313,616176,432-137,184$1.33M$649.3K0.38%-$680.5K
Voyager Therapeutics, Inc.(VYGR)75,147224,918+149,771$263.0K$602.8K0.35%+$339.8K
Sol-Gel Technologies LtdSHS NEW
SHS NEW
07,600+7,600$0$564.5K0.33%+$564.5K
Olema Oncology, Inc.(OLMA)199,00059,000-140,000$2.49M$509.8K0.29%-$1.98M
CorMedix Inc.(CRMD)065,874+65,874$0$507.2K0.29%+$507.2K
CAMP4 THERAPEUTICS CORPORATION(CAMP)120,000120,0000$524.4K$484.8K0.28%-$39.6K
Abeona Therapeutics Inc.(ABEO)090,700+90,700$0$476.2K0.28%+$476.2K
Altimmune, Inc.(ALT)152,681160,964+8,283$464.1K$460.4K0.27%-$3.8K
Vor Biopharma Inc.(VOR)024,000+24,000$0$457.9K0.26%+$457.9K
MoonLake ImmunotherapeuticsCL A(MLTX)036,220+36,220$0$423.8K0.24%+$423.8K
Aethlon Medical Inc062,837+62,837$0$409.7K0.24%+$409.7K
Pulmonx Corporation(LUNG)200,543200,000-543$260.7K$382.0K0.22%+$121.3K
Pacific Biosciences of California, Inc.(PACB)1,350,000160,000-1,190,000$2.27M$379.2K0.22%-$1.89M
Trinity Capital Inc.(TRIN)20,00020,0000$357.8K$351.0K0.20%-$6.8K
Silence Therapeutics plcADS(SLN)71,21830,000-41,218$782.0K$327.9K0.19%-$454.1K
Cullinan Therapeutics, Inc.(CGEM)20,00020,0000$364.2K$307.0K0.18%-$57.2K
Kayne Anderson BDC, Inc.(KBDC)20,00020,0000$270.6K$251.2K0.15%-$19.4K
Rezolute, Inc.(RZLT)060,296+60,296$0$249.6K0.14%+$249.6K
Entrada Therapeutics, Inc.(TRDA)036,849+36,849$0$234.0K0.14%+$234.0K
Immunic, Inc.(IMUX)021,917+21,917$0$203.8K0.12%+$203.8K
Cardiol Therapeutics Inc.CL A(CRDL)0100,000+100,000$0$166.0K0.10%+$166.0K
Ocular Therapeutix, Inc.(OCUL)20,65520,450-205$202.8K$156.9K0.09%-$46.0K
Kazia Therapeutics LtdADS016,000+16,000$0$153.5K0.09%+$153.5K
Kyntra Bio, Inc.(KYNB)22,56622,5660$170.4K$150.1K0.09%-$20.3K
Elutia Inc.(ELUT)165,094165,0940$161.7K$130.4K0.08%-$31.3K
Biomea Fusion, Inc.(BMEA)093,500+93,500$0$124.4K0.07%+$124.4K
Fractyl Health, Inc.(GUTS)0165,478+165,478$0$90.1K0.05%+$90.1K
Invivyd, Inc.(IVVD)342,27575,975-266,300$298.6K$66.1K0.04%-$232.5K
Lipocine Inc.(LPCN)16,71216,7120$42.8K$36.8K0.02%-$6.0K
DocGo Inc.(DCGO)39,06239,0620$20.2K$15.6K0.01%-$4.5K
Bristol Myers Squibb Co RtsRIGHT 12 30 2030098,527+98,527$0$12.3K0.01%+$12.3K
4d Molecular Therapeutics Inc48,5050-48,505$645.1K$0—-$645.1K
BioAge Labs, Inc.(BIOA)69,0000-69,000$1.69M$0—-$1.69M
Candel Therapeutics, Inc.(CADL)47,7560-47,756$491.9K$0—-$491.9K
Capricor Therapeutics, Inc.(CAPR)14,3520-14,352$345.6K$0—-$345.6K
COMPASS Pathways plcADS(CMPS)30,0000-30,000$424.5K$0—-$424.5K
Gossamer Bio, Inc.(GOSS)18,1760-18,176$3.0K$0—-$3.0K
Grace Therapeutics, Inc.(GRCE)120,0000-120,000$272.4K$0—-$272.4K
Karyopharm Therapeutics Inc.(KPTI)42,9520-42,952$419.6K$0—-$419.6K
Novo Nordisk A/SADR(NVO)24,0000-24,000$1.15M$0—-$1.15M
Phathom Pharmaceuticals, Inc.(PHAT)55,0000-55,000$596.8K$0—-$596.8K
Quoin Pharmaceuticals, Ltd.ADS(QNRX)20,0000-20,000$96.8K$0—-$96.8K
Savara Inc.(SVRA)80,0000-80,000$492.8K$0—-$492.8K
Structure Therapeutics IncADR24,0000-24,000$1.29M$0—-$1.29M
uniQure N.V.SHS(QURE)50,6970-50,697$2.34M$0—-$2.34M
UroGen Pharma Ltd.(URGN)16,4870-16,487$606.7K$0—-$606.7K
Vera Therapeutics, Inc.CL A(VERA)57,7580-57,758$2.48M$0—-$2.48M
Page 1 of 1
Birchview Capital, LP — 13F Holdings — Q3 2026 | TickerTrail